Tradition Wealth Management LLC Makes New $381,000 Investment in Hims & Hers Health, Inc. $HIMS

Key Points

• Tradition Wealth Management LLC acquired a new stake in Hims & Hers Health, purchasing 12,881 shares valued at approximately $381,000 in the 1st quarter.
• Insider Andrew Dudum sold 660,000 shares of the company for over $33 million, reducing his ownership by nearly 23%.
• Analysts have downgraded Hims & Hers Health from a "buy" to a "hold" rating, with a consensus price target now at $38.92.

Tradition Wealth Management LLC bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 12,881 shares of the company's stock, valued at approximately $381,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Allworth Financial LP boosted its holdings in shares of Hims & Hers Health by 20.0% during the 1st quarter. Allworth Financial LP now owns 2,006 shares of the company's stock worth $56,000 after buying an additional 334 shares during the period. Signaturefd LLC boosted its holdings in shares of Hims & Hers Health by 17.7% during the 1st quarter. Signaturefd LLC now owns 2,586 shares of the company's stock worth $76,000 after buying an additional 388 shares during the period. Larson Financial Group LLC boosted its holdings in shares of Hims & Hers Health by 47.7% during the 1st quarter. Larson Financial Group LLC now owns 1,419 shares of the company's stock worth $42,000 after buying an additional 458 shares during the period. Cim LLC boosted its holdings in shares of Hims & Hers Health by 1.0% during the 4th quarter. Cim LLC now owns 71,869 shares of the company's stock worth $1,738,000 after buying an additional 694 shares during the period. Finally, LPL Financial LLC boosted its holdings in shares of Hims & Hers Health by 0.8% during the 1st quarter. LPL Financial LLC now owns 98,701 shares of the company's stock worth $2,917,000 after buying an additional 743 shares during the period. Institutional investors own 63.52% of the company's stock.

Insider Activity at Hims & Hers Health

In related news, CFO Oluyemi Okupe sold 23,107 shares of the company's stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $47.25, for a total transaction of $1,091,805.75. Following the completion of the transaction, the chief financial officer directly owned 63,222 shares in the company, valued at $2,987,239.50. This represents a 26.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael Chi sold 17,102 shares of the company's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total transaction of $1,021,844.50. Following the transaction, the insider owned 278,654 shares of the company's stock, valued at approximately $16,649,576.50. This represents a 5.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,396,090 shares of company stock valued at $71,927,627 in the last quarter. 13.71% of the stock is owned by company insiders.

Hims & Hers Health Price Performance

Shares of NYSE:HIMS traded up $0.57 during midday trading on Friday, hitting $44.53. The stock had a trading volume of 27,930,748 shares, compared to its average volume of 34,221,508. The company's 50-day moving average price is $51.71 and its 200-day moving average price is $45.78. The company has a market capitalization of $10.06 billion, a P/E ratio of 55.66, a price-to-earnings-growth ratio of 2.97 and a beta of 2.08. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a fifty-two week low of $13.47 and a fifty-two week high of $72.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. Hims & Hers Health's quarterly revenue was up 72.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on the stock. Wall Street Zen downgraded shares of Hims & Hers Health from a "buy" rating to a "hold" rating in a report on Monday, July 28th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Hims & Hers Health in a report on Wednesday, May 7th. Citigroup reissued a "sell" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. UBS Group set a $30.00 price objective on shares of Hims & Hers Health in a report on Monday, June 23rd. Finally, Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a report on Tuesday, August 5th. Two investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Reduce" and a consensus price target of $38.92.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.